Answers are grounded in this paper and cite their sources.
The purpose of this presentation is to concentrate on three issues: Is there an explanation for the large difference in reported incidence rates of inhibitor formation in haemophiliacs? Why do not all severe patients develop inhibitors? And how on the contrary do some patients with mild haemophilia develop inhibitors?
No takes yet. Share an insight, caveat, or question.
Lee et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: